Synergy Pharmaceuticals Added to the MSCI Global Small Cap Indices

barbara.lempert NEW YORK, May 30, 2013 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, ...

iCo Therapeutics Announces First Quarter 2013 Financial Results

barbara.lempert VANCOUVER, May 29, 2013 /CNW/ – iCo Therapeutics (TSX-V: ICO), today reported financial results for the quarter ended March 31, 2013. Amounts, unless specified ...

Ibuprofen carries heart attack, stroke risks on par with Vioxx’s at high doses

Tracy Staton A study finds that common, over-the-counter pain relievers such as ibuprofen raise the risk of heart attack when taken at high doses for long periods ...

Bioniche Responds to Dissident Shareholders

barbara.lempert Bioniche Responds to Dissident Shareholders and Rejects Call for Early Shareholder Meeting BELLEVILLE, ON, May 29, 2013 /CNW/ – Bioniche Life Sciences Inc. (TSX: ...

Bristol-Myers, AstraZeneca win turnabout at NICE for Forxiga

Tracy Staton Bristol-Myers Squibb and AstraZeneca persuaded the U.K.'s cost-effectiveness agency to make an about-face on their new diabetes drug Forxiga. FiercePharma News

Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel

barbara.lempert JERUSALEM May 30, 2013-Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today that its wholly owned ...

Top 10 experimental cancer drugs – 2013

Alok Saboo In our third annual report on 10 exciting cancer drugs, there are plenty of R&D programs zipping through trials with the blessing of the FDA, which has awarded "breakthrough" ...

Biogen Idec taps brakes on EU launch of oral MS drug Tecfidera

Ryan McBride Biogen Idec has taken steps to provide a strong and durable fortress around intellectual property for its potential blockbuster Tecfidera in the European Union, but the ...

More hospitals require pediatricians to be board certified

barbara.lempert New study from University of Michigan finds 13 percent increase in hospitals that require pediatrician certification ANN ARBOR, Mich. — As hospitals face pressure ...

UCLA slams the door on GlaxoSmithKline’s latest R&D competition

John Carroll GlaxoSmithKline's latest attempt to enlist the academic community in its translational research efforts has won a chilly reception from the upper echelon of UCLA. FierceBiotech ...

France backs down on Diane 35 suspension after latest European review

Tracy Staton French health regulators say they'll usher Bayer's hormonal pill Diane 35 back onto the market, if top European watchdogs ratify the latest recommendations ...

Medicare Spending Variations Mostly Due To Health Differences, Study Concludes

barbara.lempert By Jordan Rau KHN Staff Writer The idea that uneven Medicare health care spending around the country is due to wasteful practices and overtreatment—a concept that ...
Page 4 of 34« First...23456...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS